Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 175

The DOI matches its Crossref record.

PREVENTION OF VENTRICULAR FIBRILLATION INDUCED BY CORONARY LIGATION

KAUMANN, A.J., ARAMENDIA, P. · 1968 · The Journal of Pharmacology and Experimental Therapeutics

Abstract

Ligation of the left descending coronary artery at its origin produced ventricular fibrillation in anesthetized dogs. This situation held true in untreated controls (10 dogs of 11 died between 0.8 and 19 mm after the ligature), reserpine-treated dogs (five of five) or animals pretreated with 0.5 mg/kg i.v. of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide hydrochloride (MJ 1999) (five of five). On the other hand, i.v. administration of 10 mg/kg of MJ 1999 or 0.79 mg/kg of iproveratril 10 min before the coronary ligation prevented ventricular fibrillation whether or not the animals had been pretreated with reserpine. Neither macroscopic examination of the heart nor the electrocardiogram infarction pattern showed differences between control experiments and experiments with MJ 1999 and iproveratril. Dogs injected with iproveratril survived more than 10 months. Animals pretreated with 10 mg/kg i.v. of MJ 1999 died within 24 hr after coronary ligation (except one dog that lived several months). The evidence supports the conclusion that the incidence of ventricular fibrillation induced by coronary occlusion is not related to the content of norepinephrine of the heart. Furthermore, the ability of these compounds to prevent ventricular fibrillation does not depend on a beta adrenergic blocking action.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0022-3565(25)28136-8

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 175

Metadata

Authors
KAUMANN, A. J., & ARAMENDIA, P.
Venue
The Journal of Pharmacology and Experimental Therapeutics
Publisher
Elsevier BV
Published
1968-12
Volume
164
Issue
2
Pages
326-332
ISSN
0022-3565 (ISSN-L)
OpenAlex
W1872255393
Cited by
175
References
0
FWCI
2.26
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PREVENTION OF VENTRICULAR FIBRILLATION INDUCED BY CORONARY LIGATION. https://app.cochat.ai/papers/10.1016/s0022-3565(25)28136-8
The paper
KAUMANN, A. J., & ARAMENDIA, P. (1968). PREVENTION OF VENTRICULAR FIBRILLATION INDUCED BY CORONARY LIGATION. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(25)28136-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.